These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 26894634

  • 1. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM.
    Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
    [Abstract] [Full Text] [Related]

  • 4. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
    J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
    [Abstract] [Full Text] [Related]

  • 5. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Inflamm Bowel Dis; 2014 Aug; 20(8):1341-5. PubMed ID: 24983976
    [Abstract] [Full Text] [Related]

  • 6. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S, Dahele A, Fennel J, Aitken S, Shand AG, Arnott ID, Satsangi J.
    Inflamm Bowel Dis; 2008 Jun; 14(6):756-62. PubMed ID: 18275071
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC.
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [Abstract] [Full Text] [Related]

  • 8. [The efficacy and safety of methotrexate in refractory Crohn's disease].
    Xu P, He Y, Chen Y, Chao K, Chen B, Mao R, Tang R, Zhu Z, Zeng Z, Chen M.
    Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):188-92. PubMed ID: 24767205
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 10. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
    Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J, ENEIDA registry of GETECCU.
    Br J Clin Pharmacol; 2024 May; 90(5):1301-1311. PubMed ID: 38369687
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studies.
    Hausmann J, Zabel K, Herrmann E, Schröder O.
    Inflamm Bowel Dis; 2010 Jul; 16(7):1195-202. PubMed ID: 19924799
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic role of methotrexate in pediatric Crohn's disease.
    Djurić Z, Šaranac L, Budić I, Pavlović V, Djordjević J.
    Bosn J Basic Med Sci; 2018 Aug 01; 18(3):211-216. PubMed ID: 29338679
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X.
    Inflamm Bowel Dis; 2017 Mar 01; 23(3):440-447. PubMed ID: 28129286
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
    Sprakes MB, Ford AC, Warren L, Greer D, Hamlin J.
    J Crohns Colitis; 2012 Mar 01; 6(2):143-53. PubMed ID: 22325168
    [Abstract] [Full Text] [Related]

  • 15. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
    Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.
    Digestion; 2017 Nov 01; 96(4):220-227. PubMed ID: 29065423
    [Abstract] [Full Text] [Related]

  • 16. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM, Iser JH, Gibson PR.
    J Gastroenterol Hepatol; 2008 Jun 01; 23(6):954-8. PubMed ID: 17559377
    [Abstract] [Full Text] [Related]

  • 17. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.
    J Pediatr Gastroenterol Nutr; 2009 May 01; 48(5):526-30. PubMed ID: 19412004
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S.
    Scand J Gastroenterol; 2015 May 01; 50(10):1208-13. PubMed ID: 25877164
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D, Doveh E, Cohen A, Wilson ML, Grossman AB, Rosh JR, Lu Y, Bousvaros A, Deslandres C, Noble A, Baldassano RN, Levine A, Lerner A, Wilson DC, Griffiths AM.
    Gut; 2015 Dec 01; 64(12):1898-904. PubMed ID: 25416066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.